Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPD417 (Equetro) in Bipolar I Disorder
NCT00150605Phase 3Completed
- Sponsor
- Validus Pharmaceuticals
- Start
- Feb 2005
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of carbamazepine in bipolar I disorder, sponsored by Validus Pharmaceuticals. Started Feb 2005; status: completed.
02
Drugs
carbamazepine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00150605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00150605.